Antonella Manca
Sassari, 07100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
How to treat BRAF mutant metastatic melanoma?
Journal: Personalized medicine
Published: December 01, 2025
Mutation rates in main tumour driver genes predict prognosis in patients with superficial spreading or nodular primary melanoma: results from the CARAMEL study by the Italian Melanoma Intergroup (IMI).
Journal: Experimental hematology & oncology
Published: July 29, 2025
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 29, 2025
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond.
Journal: Critical reviews in oncology/hematology
Published: January 31, 2024
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma.
Journal: International journal of molecular sciences
Published: January 06, 2023
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 26, 2022
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 02, 2022
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study.
Journal: BMC pulmonary medicine
Published: September 07, 2021
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?
Journal: Frontiers in oncology
Published: February 10, 2021
Last Updated: 09/26/2026